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We have found that several aliphatic and alicyclic diols
induce melanogenesis in cultured S91 mouse melanoma
cells and normal human epidermal melanocytes (NHEM).
In addition, these compounds induce melanogenesis
when applied to guinea pig skin, with transfer of melanin
to keratinocytes and formation of ‘‘supranuclear caps,’’
as occurs in naturally pigmented skin. The relative order
of potency of some of these diols in NHEM is 5-norbor-
nene-2,2-dimethanol > 3,3-dimethyl-1,2-butanediol > cis-
1,2-cyclopentanediol > 2,3-dimethyl-2,3-butanediol >
1,2-propanediol. Following treatment with these diols
or 3-isobutyl-1-methylxanthine, melanin and tyrosinase
activity are increased within S91 cells and NHEM; how-
ever, for cultured NHEM, the largest increases of melanin
When exposed to certain stimuli, including sunlight,melanocytes undergo a process of terminal differ-entiation that culminates in melanosome matura-tion and melanin synthesis. During this process,melanosomes are transported from melanocytes in
the basal layer of the epidermis to closely associated keratinocytes
(reviewed in Jimbow et al, 1991, 1993; Hearing and King, 1993).
Keratinocytes in the basal layer proliferate, resulting in continual
migration of keratinocytes towards the outer layers of the skin.
During this migration, keratinocytes undergo a process of terminal
differentiation that results in enhanced keratin production, loss of
organelles including nuclei, and transformation into flattened ceramide-
rich remnants of cells that comprise the stratum corneum (reviewed
in Schaefer and Fedelmeier, 1996). Migration of keratinocytes from
the basal layer of the epidermis to the bottom layer of the stratum
corneum takes 2–4 wk in humans. Bottom layers of the stratum
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and tyrosinase occur in an extracellular particulate frac-
tion, shown by electron microscopy to consist almost
entirely of stage III and IV melanosomes. These results
indicate that cultured NHEM treated with diols export
melanosomes in a fashion that is commensurate with
natural melanogenic processes. In contrast, S91 mouse
melanoma cells exhibit aberrant melanosomal trafficking,
in accordance with the known defect in myosin-V medi-
ated melanosomal transport. Both S91 cells and NHEM
exhibit morphologic changes and growth arrest indicative
of differentiation following treatment with diols. The
diols described in this report are candidates for use
as cosmeceutical tanning agents. Key words: norbornane/
tanning/tyrosinase. J Invest Dermatol 110:428–437, 1998
corneum are continually displaced by differentiating keratinocytes
resulting in further migration of melanin towards the surface of the
skin. This latter process takes an additional 2 wk and culminates in
shedding of the stratum corneum.
Sunlight is thought to induce tanning by stimulating the release of
substances from keratinocytes and other cells in the skin that cause
differentiation of melanocytes. These substances include adrenocortico-
tropic hormone, melanocyte stimulating hormone (MSH), lipotropic
hormone, endothelin-I, basic fibroblast growth factor (reviewed in
Jimbow et al, 1991, 1993; Gilchrest et al, 1996), and nitric oxide
(Romero-Graillet et al, 1997). The effect of sunlight on keratinocytes
may be wavelength dependent, with ultraviolet A inducing protein
kinase C mediated signal transduction pathways (Matsui et al, 1994),
and ultraviolet B (UVB) inducing NF-kB mediated signal transduction
pathways (Tobin et al, 1996). Both pathways can be activated as a
result of free radical and active oxygen generation (von Ruecker et al,
1989; Mohan and Meltz, 1994).
Drugs to induce melanogenesis in human melanocytes would be
useful to provide natural protection against damage from sunlight
exposure. Although sunscreens provide instant protection, they require
reapplication and can be washed off, so that continual diligence is
required to prevent photodamage (Pathak and Fitzpatrick, 1993). In
addition, several common components of sunscreens have been shown
to generate mutagenic free radicals when exposed to sunlight (Knowland
et al, 1993; Allen et al, 1996). Furthermore, sunscreens did not protect
against the development of UV induced melanomas in laboratory
studies (Wolf et al, 1994). Recent epidemiologic studies have shown
that sunscreen use is associated with an increased risk of developing
skin cancer (Westerdahl et al, 1995). In contrast, natural melanin
provides broad range protection against UVR, and may have the
additional benefit of quenching UV induced free radicals (Kochevar
et al, 1993; Pathak and Fitzpatrick, 1993). Furthermore, the presence
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of constitutive melanin in skin is associated with protection against sun
induced erythema, degenerative aging processes, and neoplastic disease
(Pathak and Fitzpatrick, 1993).
In past studies, several agents have been shown to induce melano-
genesis in cell culture, including L-3,4-dihydroxyphenylalanine acid
(L-Dopa), L-Dopa phosphates, 3,4-dihydroxyphenylalanine (Dopac),
NH4Cl, MSH, diacylglycerol, and 3-isobutyl-1-methylxanthine
(IBMX) (Pawelek and Murray, 1986; McLane et al, 1987; Slominski
et al, 1988; Karg et al, 1989; Gordon and Gilchrest, 1989; Karg et al,
1993; Fuller et al, 1993). It is unclear at this time if any of these agents
will have a practical application as tanning agents. Induction of
melanogenesis by L-Dopa and Dopac is accompanied by onset of toxic
effects in S91 cells (Pawelek and Murray, 1986; Karg et al, 1989). L-
Dopa phosphates are far less toxic than L-Dopa, but do not directly
induce melanogenesis; rather they rely on concomitant treatment with
MSH (McLane et al, 1987). In clinical studies with MSH and MSH
analogs, injection was required for administration, and tanning occurred
primarily in areas previously exposed to sunlight, so that tanning was
uneven (Levine et al, 1991; Dorr et al, 1996). The use of diacylglycerol
may be limited because it is a potential inducer of inflammation and
has the properties of cancer promoters (Allan et al, 1995). IBMX is a
strong inducer of melanogenesis in cell culture, but has not yet been
demonstrated to be an effective tanning agent when applied to
human skin.
In this study, we report that many aliphatic and alicyclic diols can
induce melanogenesis in cell culture and when applied to guinea pig
skin. The melanogenic potency of these diols ranges from very low
for propanediols to relatively high for the norbornane (NBane) related
diols. Some of these compounds induce differentiation of melanoma
cells, suggesting their potential as cancer therapeutic agents.
MATERIALS AND METHODS
Materials 1,2-propanediol (1,2-PD), 2,3-butanediol (2,3-BD), IBMX, α-
melanocyte stimulating hormone (α-MSH), L-Dopa, Dopac, ethanol (ETOH),
1-propanol, 2-propanol, ascorbic acid, oleic acid, glycerol, ethylene glycol,
cholera toxin (CT), melanin, and catalase were from Sigma (St. Louis, MO).
2,3-dimethyl-2,3-butanediol (2,3-DM-2,3-BD), 2-methyl-1,3-propanediol (2-
M-1,3-PD), 1,2-cis-cyclopentanediol (1,2-cs-CPD), 3,3-dimethyl-1,2-butane-
diol (3,3-DM-1,2-BD), 5-norbornene-2,2-dimethanol (5-NBene-2,2-DM), α-
norborneol (α-NBane-ol), 2-norbornanemethanol (2-NBaneM), tartaric acid,
D-ribose, D-Deoxyribose, and 2-pyrrolidone were from Aldrich (Milwaukee,
WI). Azone was from Durham Pharmaceuticals (Durham, NC). L-[3,5–3H]-
tyrosine was from NEN (Boston, MA). Norbornane-2,2-dimethanol (NBane-
2,2-DM) was prepared by catalytic (Pd/charcoal) hydrogenation of 5-norbor-
nene-2,2-dimethanol. 2,3-Cis/exo-norbornanediol (2,3-c/e-NBaneD) was
synthesized from norbornene by selective oxidation (OsO4) of double bonds.
Thymidine glycol (cis-5,6-dihydroxy-5,6-dihydrothymidine) and thymine glycol
(cis-5,6-dihydroxy-5,6-dihydrothymine) were prepared by potassium perman-
ganate (KMnO4) oxidation of thymidine or thymine, respectively, according
to Frenkel et al (1981). 5-Hydroxymethyluracil was synthesized by hydroxy-
methylation of uracil with formaldehyde/potassium hydroxide as reported by
Cline et al (1959).
Cell cultures and treatments Cloudman S91 mouse melanoma cells were
obtained from the American Type Culture Collection (ATCC) and cultured in
modified Eagle’s medium (BioWhittaker, Waltersville, MD) with 10% calf
serum (BioWhittaker or Hyclone, Logan, UT). Cells were plated at 105 cells
per well in 6 well plates the day before treatment, in media containing 10%
calf serum. Media was changed to modified Eagle’s medium with 2% calf serum
concomitant with addition of treatments (Eller et al, 1996). Treatments were
added to cell culture media either neat or dissolved in ethanol or water.
Normal human epidermal melanocytes (NHEM) from black-neonatal (Bl-
Neo) male (Lot. 14466), white-neonatal (Wh-Neo) male (Lot. 13043), and
white-adult (Wh-Ad) female (Lot. 14604) donors were obtained from Clonetics
(San Diego, CA), and cultured exactly as prescribed by the supplier, except for
experiments in which alternative culture conditions were employed as noted
below. Media was Clonetics Melanocyte Growth Medium-3 BulletKitR with
constituents at a final concentration of 0.5% fetal bovine serum, 7.5 µg bovine
pituitary extract per ml, 2 ng human recombinant fibroblast growth factor per
ml, 16 nM phorbol myristate acetate (PMA), 10 µg insulin per ml, 10 µg
hydrocortisone per ml, 100 µg gentamicin per ml, and 100 ng amphotericin-
B per ml in Clonetics Melanocyte Growth Medium (MGMR). Cells were
cultured for at least 2 wk in alternative culture conditions – either without
PMA but with 10 nM cholera toxin (No PMA/1CT) or without PMA or
CT (No PMA/No CT) – before addition of treatments. Cells were plated at
105 cells/P60 2–4 d before addition of treatments. Treatments were as described
above for S91 cells.
Melanin analysis Media was removed from cells. S91 cells were washed
twice with 2 ml 1XPBS (BioWhittaker), detached with 0.05% trypsin/
ethylenediamine tetraacetic acid (BioWhittaker), and counted on a Coulter
(Hialeah, FL) counter. NHEM were washed once with 3 ml HEPES buffered
saline solution (Clonetics), detached with 2 ml of 0.025% trypsin/ethylenediam-
ine tetraacetic acid (Clonetics), and similarly counted. S91 or NHEM were
centrifuged at 200 3 g for 5 min, and then washed with 1XPBS. Cells were
solubilized in 1N NaOH by vigorous vortexing. In some cases, media was
retained and centrifuged at 1600 3 g for 5 min for analysis of melanin in the
extracellular particulate fraction, using the same procedures as for cells. Melanin
was measured as absorbance at 475 nm, by comparison with melanin standards.
Melanin was calculated per cell.
Tyrosinase analysis Cells were trypsinized, counted, and pelleted as described
above for melanin assays. In some cases, media was retained and centrifuged at
1600 3 g for 5 min for analysis of tyrosinase activity in the extracellular
particulate fraction and in the supernatant media fraction, using modifications
of procedures described by Pomerantz (1966), Jara et al (1988), and Gilchrest
et al (1993). Each sample was analyzed with and without L-Dopa, a necessary
cofactor for tyrosinase (Pomerantz, 1966; McLane et al, 1987). All reported
tyrosinase values are exclusive of counts that occurred in buffer blanks and L-
Dopa negative aliquots. Protein was determined by the Bradford method
(Bradford, 1976).
Electron microscopy of extracellular particulate fraction The extra-
cellular particulate fraction was collected from untreated or 5 mM 5-NBene-
2,2-DM treated Bl-Neo NHEM by centrifuging media at 1600 3 g for 5 min
and washing twice in 0.12 M phosphate buffer pH 7.4. Melanosome pellets
were initially fixed with 2% glutaraldehyde in 0.12 M phosphate buffer, followed
by a postfixation in 1% osmium tetroxide in the same buffer, and then en bloc
staining with 2% aqueous uranyl acetate. Samples were dehydrated with a
graded ethanol series (35%–100%), followed by treatment with propylene oxide.
Samples were then embedded in Spurr’s epoxy resin and thin sections were
mounted on copper grids. These were further stained with uranyl acetate and
lead citrate before viewing in a Zeiss (Oberkochen, Germany) EM10 CA
electron microscope operated at 80 KV.
Treatment of guinea pigs American short-haired guinea pigs were obtained
from Kuiper Rabbit Ranch (Chicago, IL). Animals were maintained and treated
at Biocon (Rockville, MD). Three days prior to initiation of treatments, the
backs of guinea pigs were shaved. On the day treatments began, fur-free
treatment spots were created by application of the depilatory agent Nair (Carter-
Wallace, New York, NY) for 15 min. Test agents were applied twice a day for
5 d at 20 µl per application. In the first set of experiments (see Fig 7A, B;
Table III), treatment agents were full strength (13.6 M) 1,2-PD, full strength
(11.26 M) 2-M-1,3-PD, and full strength (10.95 M) 2,3-BD. In the second set
of experiments, treatments agents were 10.95 M 1,2-PD in 20% ETOH, 4 M
3,3-DM-1,2-BD in 20% ETOH, or 8.7 M 1,2-cs-CPD in 20% ETOH (see
Figs 7C, 8A; Table III). In the third set of experiments treatment agents were
2% 2-pyrrolidone in 20% ETOH (2P), 10.6 M 1,2-PD in 20% ETOH and 2%
2-pyrrolidone (1,2-PD/2P), 1 M 5-norbornene-2,2-dimethanol in 20% ETOH
and 2% 2-pyrrolidone (5-NBene-2,2-DM/2P), and 1 M 5-NBene-2,2-DM in
8.5 M 1,2-PD, 20% ETOH, and 2% 2-pyrrolidone (5-NBene-2,2-DM/1,2-
PD/2P) (see Fig 8C, D; Table III). Two weeks after the cessation of treatments,
backs of guinea pigs were shaved and treated with Nair to remove all fur.
Treatment spots were then subjectively evaluated for degree of melanogenesis
according to the following scale: 0, no change from background; 10.25, slight
darkening, indistinct; 10.5, slight darkening; 11, slight to moderate darkening;
12, moderate, even darkening; 13, substantial, even darkening; 14, profound,
even darkening. Animals were recorded on videotape for generation of the
images shown in Fig 8. Punch biopsies were collected from the center of
treatment spots and fixed in 10% formalin for standard histologic preparation,
followed by staining by Fontana-Masson or hematoxylin and eosin.
RESULTS
Diols increase melanin levels in S91 melanoma cells During
the course of screening for melanogenic compounds we found several
aliphatic and alicyclic diols that induced melanogenesis in S91 mouse
melanoma cells (Figs 1, 2A). For each compound an initial dose
range was determined, followed by a dose response analysis over a
much narrower concentration range. In at least a dozen different
experiments, 100–300 mM 1,2-PD induced a dose dependent increase
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Figure 1. Structure of diols examined in this study. Abbreviations are
given in parentheses below the name of each compound.
of melanin in S91 cells, with maximal induction in the 3–4-fold range
(e.g., Fig 2A). 2-M-1,3-PD and 2,3-DM-2,3-BD were more potent,
exhibiting a similar magnitude of induction but with treatments in the
50–100 mM and 12.5–50 mM range, respectively (Fig 2A). 1,2-cs-
CPD, 3,3-DM-1,2-BD, and 5-NBene-2,2-DM were even more
potent, with melanin induction in the 5–8-fold range at 50 mM,
25 mM, and 5 mM, respectively (Fig 2A). IBMX or α-MSH were
utilized as positive controls in all experiments, and consistently induced
6–8-fold induction of melanin at 0.1 mM and 0.1 µM, respectively
(Fig 2A). Melanogenesis was not induced in S91 cells by ethanol, 1-
propanol, 2-propanol, ascorbic acid, tartaric acid, 2-pyrrolidone, oleic
acid, Azone, D-ribose, D-Deoxyribose, thymidine glycol, thymine
glycol, or hydroxymethylurea when tested up to toxic concentrations
(data not shown). Other compounds that did not induce melanogenesis
when tested at subtoxic levels included glycerol and ethylene glycol
(data not shown).
Diols increase tyrosinase activity in S91 melanoma cells To
further confirm the melanogenic activity of diols, we examined
tyrosinase activity in extracts of S91 cells (Fig 2B) treated with
concentrations of diols that increased melanin levels 3–8-fold in S91
cells (Fig 2A). In accordance with results for induction of melanin,
3,3-DM-1,2-BD and 5-NBene-2,2-DM were not only melanogenic
at lower concentrations than 1,2-PD, but also induced higher levels
of tyrosinase activity.
5-NBene-2,2-DM and NBane-2,2-DM exhibit equivalent mela-
nogenic potency in S91 cells Because 5-NBene-2,2-DM was the
most potent melanogenic diol of those tested in S91 cells, further
studies were carried out to determine how melanogenic activity varied
with the structure of norbornene and NBane analogs. Results indicate
that 5-NBene-2,2-DM and NBane-2,2-DM have virtually equivalent
potency for induction of tyrosinase in S91 cells (Fig 3). When tested
at 5 mM, less tyrosinase activity was induced in S91 cells by other
NBane analogs, in the following order of potency: 2-NBaneM . 2,3-
c/e-NBaneD . α-NBane-ol . NBane. 2,3-c/e-NBaneD and α-
NBane-ol exhibited similar potency at 1 mM and 5 mM.
Diols induce morphologic differentiation and reduce prolifera-
tion of S91 melanoma cells The diols induced morphologic
differentiation of S91 cells as evidenced by conversion from a predomi-
nantly rounded bipolar morphology in untreated cells, to a flattened
multipolar morphology in treated cells (Fig 4). Acquisition of the
flattened multipolar phenotype was associated with dramatic increases
in the time required to detach S91 cells from dishes by trypsin,
suggesting a change in the interaction of the cells with the extracellular
matrix. Furthermore, morphologic differentiation of S91 cells was
Figure 2. Diols increase melanin content and tyrosinase activity of
S91 mouse melanoma cells. Cells (105) were treated with the indicated
concentrations of diols, IBMX, or α-MSH and harvested 6 d later for analysis
of melanin content or tyrosinase activity. (A) Induction of melanin by diols,
IBMX, and α-MSH in S91 mouse melanoma cells. Melanin was extracted with
NaOH and measured by optical density at 475 nm. Values are relative
to untreated controls. 1,2-PD, 1,2-propanediol; 2-M-1,3-PD, 2-methyl-1,3-
propanediol; 2,3-DM-2,3-BD, 2,3-dimethyl-2,3-butanediol; 1,2-cs-CPD, 1,2-
cis-cyclopentanediol; 3,3-DM-1,2-BD, 3,3-dimethyl-1,2-butanediol; 5-Nbene-
2,2-DM, 5-norbornene-2,2-dimethanol; IBMX, 3-isobutyl-1-methylxanthine;
α-MSH, α-melanocyte stimulating hormone. (B) Induction of tyrosinase by
diols and IBMX in S91 mouse melanoma cells. Tyrosinase activity was measured
in cell extracts by tritium release from L-[3,5-3H]tyrosine and normalized to
cellular protein. Values are mean 6 SEM (N 5 4 for Control, 1,2-PD, and 5-
NBene-2,2-DM; N 5 2 for 1,2-cs-CPD, 3,3-DM-1,2-BD, and IBMX;
*p , 0.05; Students t test).
accompanied by up to 3-fold increases of protein/cell for 5 mM 5-
NBene-2,2-DM and 25 mM 3,3-DM-1,2-BD (data not shown). At
the end of the incubation period untreated cells typically showed a 5-
fold increase in cell number, whereas the cells treated with the
compounds increased by about a third of the control value. It is
important to emphasize that the reductions of cell growth induced by
diols were never accompanied by rounding or detachment of cells or
a decline in cell numbers relative to the starting plating density.
Diols induce the greatest increases of melanin in the extracellular
particulate fraction of NHEM The preceding experiments were
performed with tumor derived S91 mouse melanoma cells. We were
interested in measuring the activity of the diols on primary human
melanocytes in culture. As described in Materials and Methods, we used
preparations of NHEM derived from Wh-Neo or Wh-Ad donors as
well as cells from a Bl-Neo donor. Published work indicated that
treatment of primary human melanocytes with IBMX, UVR, or other
agents resulted in only modest increases in cellular melanin content
(Abdel-Malek et al, 1992, 1994; Fuller et al, 1993). In our initial
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Figure 3. 5-NBene-2,2-DM and NBane-2,2-DM induce equivalent
tyrosinase activity in S91 cells. When tested at 5 mM, NBane analogs
induced tyrosinase activity in the following relative order of potency: 5-
norbornene-2,2-dimethanol (5-NBene-2,2-DM) . norbornane-2,2-
dimethanol (NBane-2,2-DM) . 2-norbornanemethanol (2-NBaneM) . 2,3-
cis/exo-norbornanediol (2,3-c/e-NBaneD) . α-norbornaneol (α-NBaneM) .
norbornane (NBane). Tyrosinase activity was measured in cell extracts by release
of tritium from L-[3,5-3H]tyrosine. Values are relative to untreated controls.
Table I. Induction of melanin (ng per 103 cells) in cells and in
the extracellular particulate fraction of NHEM from a
Wh-Neo male donor treated with diols
Cellular 1600 3 g Partic
Control 20 (1.03) 1.0 (1.03)
25 mM 2,3-DM-2,3-BD 20 (1.03) 0.7 (0.73)
50 mM 2,3-DM-2,3-BD 31 (1.63) 3.9 (3.93)
25 mM 1,2-cs-CPD 21 (1.13) 2.9 (2.93)
50 mM 1,2-cs-CPD 29 (1.53) 13 (133)
12.5 mM 3,3-DM-1,2-BD 31 (1.63) 5.9 (5.93)
25 mM 3,3-DM-1,2-BD 41 (2.13) 30 (303)
experiments we also observed that the diols as well as IBMX induced
only small increases (1.5–2-fold) in melanin levels in NHEM, results
that were consistent with the literature; however, we noted a marked
increase in the presence of dark brown colored particulate material
floating in the media of diol and IBMX treated Wh-Neo NHEM
cells. Because we suspected this particulate material might contain
exported membrane bound melanosomes of the type previously seen
in recipient keratinocytes (Szabo et al, 1969), we sedimented this
particulate material from media by centrifugation at 1600 3 g and
measured melanin levels. Although cellular melanin levels were
increased no more than 2-fold in the Wh-Neo NHEM treated with
diols, melanin in the extracellular particulate fraction was increased up
to 30-fold relative to untreated controls (Table I). Consequently, in
subsequent studies in which tyrosinase was measured, measurements
were done on both cellular and extracellular particulate fractions
(see below).
Diols induce the greatest increases of tyrosinase in the extra-
cellular particulate fraction of NHEM Tyrosinase was measured
in NHEM using procedures identical to those for S91 cells (Fuller
et al, 1993). In addition, media from 5 d treatment periods was retained
and centrifuged at 1600 3 g for analysis of tyrosinase activity in the
extracellular particulate fraction, and in the resultant supernatant media
fraction. In some cases (Table II), tyrosinase was also measured by an
in situ assay wherein radiolabeled tyrosine was added directly to freshly
replaced media of NHEM for a period of 24 h following a 6 d
treatment period (Abdel-Malek et al, 1992).
Results using Bl-Neo NHEM showed that of the diols tested, 5 mM
5-NBene-2,2-DM induced the highest levels of tyrosinase in the in
situ assay, in cellular extracts, in the extracellular particulate fractions,
and in the media. Both 5 mM 5-NBene-2,2-DM and 25 mM 3,3-
DM-1,2-BD induced more tyrosinase in each of these assays/fractions
than did 300 mM 1,2-PD. IBMX, used as a positive control, induced
as much tyrosinase activity as 5 mM 5-NBene-2,2-DM when measured
by the in situ assay, but less in cellular, extracellular particulate, and
media fractions (Table II). The largest increases of tyrosinase relative
to controls occurred in the particulate fraction, followed by the media
fraction, and the cellular fraction. Although in situ and cellular assays
showed different absolute amounts of tyrosinase activity, for the most
part these assays showed similar relative induction of tyrosinase with
treatments.
The appearance of enhanced tyrosinase activity in the particulate
fraction also occurred in melanocytes from white donors. Treatment
of Wh-Ad NHEM with diols or IBMX resulted in increases of
tyrosinase in the 1600 3 g extracellular particulate fraction comparable
with those induced in Bl-Neo NHEM (Fig 5). For both Bl and Wh
NHEM, induction of extracellular particulate tyrosinase was greater in
1PMA/No CT media than in No PMA/1CT media (data not
shown). Similar to the results of Abdel-Malek et al (1992), cells cultured
in No PMA/No CT media grew poorly and showed little or no
response to treatments (data not shown). Tyrosinase activity was
undetectable in similarly collected extracellular fractions from S91 cells
treated with concentrations of diols or IBMX that induced maximal
increases of S91 cellular tyrosinase (data not shown).
Diols induce morphologic differentiation of normal human
epidermal melanocytes Similar to the results for S91 cells, diols
induced conversion of NHEM from a bipolar phenotype to a multiden-
dritic phenotype (Fig 6A, B), accompanied by reductions in cell
growth of up to 2-fold for 25 mM 3,3-DM-1,2-BD and 5 mM 5-
NBene-2,2-DM relative to untreated controls (data not shown). Again,
as with the S91 cells, there were no reductions of cell numbers below
the original number plated. Dark particulate material could be observed
within dendrites and in vesicles at the end of dendrites (Fig 6A, B).
Some of these vesicles appeared to be pinching off from the ends of
dendrites concomitant with increases in the levels of melanoma and
tyrosinase in the extracellular particulate fraction (Figs 5, 6C, D,
Tables I and II). Unlike S91 cells, morphologic differentiation of
NHEM was accompanied by only very small increases of protein/cell
(up to 1.5-fold), and no increases of the time required to detach cells
from dishes by trypsin (data not shown).
Electron microscopy shows that the extracellular particulate
fraction of NHEM is composed primarily of melano-
somes Increases of both melanin and tyrosinase in the extracellular
particulate fraction of NHEM strongly suggested that this fraction
was enriched in melanosomes. Subsequent studies showed that the
lysosomal/melanosomal enzyme β-glucuronidase (Fishman et al, 1967)
was enriched 3–4-fold (normalized to protein) in the extracellular
particulate fraction of NHEM treated with diols or IBMX relative to
untreated controls (data not shown). To verify the presence of
melanosomes, the extracellular particulate fraction was sedimented by
centrifugation at 1600 3 g and examined by electron microscopy.
Results showed that this fraction was composed almost exclusively of
melanosomes, most of which exhibited a striated or solid matrix
indicative of stage III or IV melanosomes, respectively (Fig 6C, D).
Although there were many fold more melanosomes in the extracellular
particulates fraction of 5-NBene-2,2-DM treated Bl-Neo-NHEM
relative to untreated controls, there were no readily apparent qualitative
differences in the ultrastructure of melanosomes as a result of treatment.
Diols induce melanogenesis when applied to guinea pig skin
Following treatment with UVR or UVR and MSH, melanocytes are
distributed in guinea pig skin similarly to their distribution in human
skin (Bolognia et al, 1989). We were interested in determining if diols
would also induce melanogenesis in this animal model. In our initial
experiments we found that treatment of shaved and Naired patches
indicated a clear positional effect, whereby the effect of agents was
greatest towards the heads of animals and significantly less towards the
tail regions. For example, treatment with undiluted 1,2-PD (13.91 M)
resulted in an unambiguous melanogenic response in anterior treatment
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Figure 4. Diols increase melanin content and induce morphologic differentiation of S91 mouse melanoma cells. Untreated S91 cells exhibit a rounded
and bipolar phenotype, whereas cells treated with diols exhibit a flattened multipolar phenotype with extended dendritic processes. Cells were treated with the
indicated concentrations of diols and photographed (unstained) 6 d later. (A) Untreated; (B) 300 mM 1,2-propanediol; (C) 25 mM 3,3-dimethyl-1,2-butanediol;
(D) 5 mM 5-norbornene-2,2-dimethanol. Arrows indicate extended dendritic processes. Scale bars, 50 µm.
Table II. Comparison of tyrosinase (dpm per h per 103 cells) activity measured in an in situ assay with tyrosinase
measured in cellular extracts, extracts of extracellular particulate fractions, and media of NHEM from a Bl-Neo donor treated
with diols or IBMX
In situ Cellular 1600 3 g Partic Mediaa
Control 16.8 10259 341 1457
85 mM ETOH 15.0 (1.003) 10201 (1.003) 574 (1.03) 1654 (1.003)
300 mM 1,2-PD 16.8 10247 535 1864
300 mM 1,2-PD 17.2 (1.073) 10875 (1.033) 1164 (1.93) 2123 (1.33)
25 mM 3,3-DM-1,2-BD 20.5 11728 2182 5495
25 mM 3,3-DM-1,2-BD 21.0 (1.313) 11730 (1.153) 2651 (5.33) 3056 (2.83)
5 mM 5-NBene-2,2-DM 24.5 13838 6940 4164
5 mM 5-NBene-2,2-DM 25.4 (1.573) 14716 (1.403) 6764 (15.03) 4639 (2.833)
0.1 mM IBMX 25.3 10910 2409 2698
0.1 mM IBMX 26.1 (1.623) 11737 (1.113) 2094 (4.93) 2935 (1.813)
aPost 1600 3 g.
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Table III. Comparison of pigmentation response in the
posterior half of guinea pigs treated with diols, with and
without the penetration enhancer 2P. Results are normalized
to 1,2-PD for comparison of relative potency
Pigmentation treatment Rating Normalized to
1,2-PDa
No penetration enhancer
Nair 0.08 6 0.05 (n 5 6)
13.61 M 1,2-PD 0.29 6 0.09 (n 5 12) 1.03
11.0 M 2,3-DM-2,3-BD 0.25 6 0.14 (n 5 3) 1.03
11.3 M 2-M-1,3-PD 0.58 6 0.08b (n 5 3) 2.93
8.7 M 1,2-cs-CPD 1.89 6 0.27b (n 5 9) 13.53
4.0 M 3,3-DM-1,2-BD 1.17 6 0.44b (n 5 3) 18.13
Penetration enhancer 2% 2P
2P 0.17 6 0.08 (n 5 6)
10.6 M 1,2-PD/2P 0.33 6 0.05 (n 5 6) 1.03
1.0 M 5-NBene-2,2-DM/2P 0.66 6 0.05b (n 5 6) 32.73
1.0 M 5-NBene-2,2-DM/ 1.00 6 0.13b (n 5 6) 44.73
8.5 M 1,2-PD/2P
aBackground corrected for Nair or vehicle treated control spots.
bp , 0.05; Students t test.
Figure 5. The media of NHEM treated with diols or IBMX contains an
extracellular particulate fraction that is enriched in tyrosinase. NHEM
(105) from a neonatal black donor were treated with the indicated concentrations
of diols or 3-isobutyl-1-methylxanthine (IBMX), and the extracellular particulate
fraction was harvested 6 d later by centrifugation at 1600 3 g. Tyrosinase
activity was measured in extracts of the extracellular particulate fraction by
tritium release from L-[3,5-3H]tyrosine. Results were normalized to protein
content of extracellular particulate fractions. Induction of tyrosinase by diols
and IBMX in the extracellular particulate fraction was similar for Wh-Ad female
and Bl-Neo male NHEM. 1,2-PD, 1,2-propanediol; 3,3-DM-1,2-BD, 3,3-
dimethyl-1,2-butanediol; 5-NBene-2,2-DM, 5-norbornene-2,2-dimethanol.
Mean 6 SEM (N 5 2; *p , 0.05; Students t test).
spots, whereas posterior treatment spots showed either marginal or
negligible effects (Fig 7A). Both 2-M-1,3-PD and 2,3-BD resulted in
a slightly greater melanogenic response than 1,2-PD when applied to
guinea pigs and compared within equivalent anterior-posterior treat-
ment locations (Fig 7B). When 3,3-DM-1,2-BD and 1,2-cs-CPD
were applied to posterior regions of animals, they resulted in a much
greater melanogenic response than 1,2-PD when applied at the same
treatment locations (Fig 7C).
In order to minimize the effects of diminution of response from the
head to the tails of animals, all subsequent data analyses (Table III)
were carried out using only treatment spots located on the posterior
half of animals (spots c or d, Figs 7, 8). In this area of the
animals, differences of responsiveness to strong and weak inducers of
pigmentation, as deduced from cell culture, were greatest (e.g., Fig 8B–
D). The compounds were either applied neat or dissolved in as high
a concentration as possible in ETOH, or ETOH with the penetration
enhancer 2-pyrrolidone (2P). Comparison of treatment spots in the
posterior half of animals showed the following descending order of
pigmentation response: 8.7 M 1,2-cs-CPD . 4 M 3,3-M-1,2-BD .
8.5 M 1,2-PD/1 M 5-NBene-2,2-DM/2% 2P . 1 M 5-NBene-2,2-
DM/2% 2P . 11.3 M 2-M-1,3-PD (Table III). In the posterior half
of animals, responses to 13.61 M 1,2-PD, 10.6 M 1,2-PD/2% 2P, and
11 M 2,3-DM-2,3-BD were not significantly different from control
(Nair or 2% 2P treated) spots. Pigmentation ratings were corrected for
background (control treatment spots), normalized to account for the
different amounts of each agent applied, and then normalized to results
for 1,2-PD (Table III). This comparison showed that the descending
order of relative potency was 5-NBene-2,2-DM . 3,3-DM-1,2-BD
. 1,2-cs-CPD .. 2-M-1,3-PD, and that using 1,2-PD as carrier
for 5-NBene-2,2-DM increased responsiveness to this compound.
Although we did employ 2P as a penetration enhancer with some of
the compounds, delivery of the compounds was not optimized. In the
case of 5-NBene-2,2-DM, undissolved compound was visible on the
surface of the skin after application, suggesting that the potency
assessment is likely to be underestimated.
Biopsies taken from the posterior half of guinea pigs showed that
induction of melanogenesis was marked by deposition of melanin in
keratinocytes, in some cases with formation of ‘‘supranuclear caps’’
(Fig 9B, D), indicative of induction of true natural UV protective
melanogenesis (Gates and Zimmermann, 1953). Skin biopsies taken
from untreated guinea pigs exhibited melanocytes and melanin in the
basal layer of the epidermis only (Fig 9A). Biopsies taken from the
posterior half of guinea pigs showed very little response to treatment
with 1,2-PD (Fig 9C). Biopsies from animals treated with 3,3-DM-
1,2-BD, 1,2-cs-CPD, or 5-NBene-2,2-DM or 5-NBene-2,2-DM/
1,2-PD exhibited increased melanin in the basal layer of the epidermis,
increased melanin in epidermal keratinocytes, and increased thickness
of the epidermis (Fig 9B, D, and data not shown). Examination of
biopsies stained by hematoxylin and eosin exhibited no signs of
inflammation or scarring from treatment with diols (data not shown).
DISCUSSION
This study is the first to demonstrate that several aliphatic and alicyclic
diols can induce melanogenesis. This induction has been demonstrated
in several different model systems, including cultured S91 mouse
melanoma cells, cultured NHEM, and guinea pig skin. In skin,
melanogenesis in vivo is thought to occur primarily as a result of
cofactors released from keratinocytes, fibroblasts, and other cells in the
skin as a result of UV irradiation (reviewed in Jimbow et al, 1991,
1993; Gilchrest et al, 1996); however, results presented here using
cultured S91 cells and NHEM show that diols act directly on
melanocytes, without the necessity of an exogenous cellular source of
cofactors. Thus, in guinea pig skin, it is likely that diols stimulate
melanogenesis by direct action on melanocytes, although the possibility
of additional indirect effects cannot be excluded.
Although treatment with diols or IBMX resulted in large increases
of melanin and tyrosinase within S91 cells, such increases were relatively
small within NHEM. Rather, treatment of NHEM with diols or
IBMX resulted in dramatic increases of melanin and tyrosinase in an
extracellular particulate fraction, shown by electron microscopy to
consist almost entirely of phase III and IV melanosomes. Additionally,
microscopic observation of NHEM indicated that treatment with
diols resulted in induction of a profoundly differentiated phenotype
characterized by arrest of cell division and acquisition of a multidendritic
morphology. Moreover, induction of this phenotype by diols or IBMX
was characterized by an apparent budding process wherein granular
appearing vesicles were observed in various stages of development and
release from dendrites. Release of melanosomes from melanocytes
occurs as a component of the natural melanogenic process whereby
melanosomes are transferred to keratinocytes that proliferate and carry
melanin towards the surface of the skin (reviewed in Jimbow et al,
1991, 1993). Our results indicate that in cell culture, in the absence
of keratinocytes, the melanosomal fraction accumulates in the media.
Recent studies indicate that S91 mouse melanoma cells are unable
to export melanosomes because of a defective myosin-V transport
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Figure 6. Cultured NHEM treated with 5-NBene-2,2-DM secrete melanosomes into the media. Photographs of unstained cultures of Bl-Neo male
NHEM showing formation of secretory vesicles (arrows): (A) untreated; (B) 5-NBene-2,2-DM. Scale bars, 25 µm. (C) and (D) Electron micrographs of the
extracellular particulate fraction from 5-NBene-2,2-DM treated Bl-Neo male NHEM showing striated melanosomal matrix in longitudinal (arrows) and cross-
sectional (arrowheads) views. Scale bars, 0.25 µm.
system (Wu et al, 1997). In accordance with this finding, our results
show that upon treatment with diols, S91 melanoma cells do not
export melanin or tyrosinase, but rather accumulate these intracellularly.
Although it has been suggested that L-Dopa or X-irradiation can result
in the release of tyrosinase into the media as a result of membrane
damage or cell disintegration (Schachtschabel et al, 1988), the absence
of extracellular tyrosinase in the media of myosin-V defective S91 cells
treated with diols or IBMX indicates that these agents are not acting
via such a mechanism. In addition, unlike L-Dopa and X-irradiation
that cause leakage and reductions of cellular protein levels
(Schachtschabel et al, 1988), diols and IBMX result in increases of
protein levels in both S91 cells and NHEM.
Treatment with the diols described in this study transformed S91
cells from a rounded bipolar phenotype to a flattened multipolar
cuboidal phenotype. Concomitant with this transformation, there was
a dramatic reduction of proliferation of the cells, increased pigmentation,
and increased adherence to substrate (monitored by increased trypsin
detachment time). Similar morphologic changes and effects on prolifera-
tion, consistent with terminal differentiation, have been reported for
S91 cells treated with phenylacetate and phenylbutyrate (Liu et al,
1994, 1995), and retinoids (Lauharanta et al, 1985). These compounds
are now in clinical trials as anti-cancer differentiation agents (Thibault
et al, 1994; Moon et al, 1997). Several of the compounds described in
this study, most notably the norbornanediol and related compounds,
are active in the same 1–5 mM concentration range as phenylacetate
and phenylbutyrate (Liu et al, 1994, 1995). Further studies are needed
to ascertain if the diols described in this study have in vivo anti-cancer
activity in animal models.
The involvement of protein kinase C and protein kinase A pathways
in the induction of melanogenesis by the diols is an important question.
In preliminary experiments (D. Brown et al, in preparation) our results
suggest that, like the situation with UVR (Friedmann and Gilchrest,
1987; Carsberg et al, 1994; Romero-Graillet et al, 1996), induction of
melanogenesis by diols does not appear to be dependent on stimulation
of protein kinase A and protein kinase C pathways. Furthermore,
addition of catalase to the culture media did not alter the melanogenic
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Figure 7. Guinea pigs treated with diols show a diminished pigmentation
response along the anterior-posterior axis. Pigmentation ratings of guinea
pigs treated with the following. (A) 13.61 M 1,2-PD showing diminution of
response along the anterior-posterior axis (see lower row a–d in Fig 8B, and
upper row a–d in Fig 8C, D). *Significantly different (p , 0.05 Students t
test; mean 6 SEM, N 5 6) from 1,2-PD treated spot nearest head. (B) 11.26 M
2-M-1,3-PD and 10.95 M 2,3-BD showing diminution of response along the
anterior-posterior axis. *Significantly different (p , 0.05 Students t test; mean
6 SEM, N 5 3) than 1,2-PD treated spot at same posterior-anterior location
in (A). (C) Nair (control), 10.95 M 1,2-PD, 4 M 3,3-DM-1,2-BD, and 8.7 M
1,2-cs-CPD in 20% ETOH (see row a–d in Fig 8A) showing markedly
increased responsiveness to 3,3-DM-1,2-BD and 1,2-cs-CPD in the posterior
regions of animals relative to compounds tested in (A) and (B). *Significantly
different (p , 0.05 Students t test; mean 6 SEM, N 5 3) than 1,2-PD treated
spot at same posterior-anterior location in (A).
response to diols (D. Brown et al, unpublished), suggesting that unlike
Dopac and other catechols, diols do not act by melanogenic mechanisms
involving quinone formation (Karg et al, 1989, 1991, 1993). Additional
studies will be required to delineate the signal transduction pathways
stimulated by the diols.
Treatment of guinea pigs with diols resulted in melanogenic responses
that were virtually identical to those that resulted from treatment of
guinea pigs with UVB or UVB 1 MSH (Bolognia et al, 1989), in that
melanin was distributed to keratinocytes and the thickness of the
epidermis was approximately doubled. In addition, treatment of guinea
pig skin with 1,2-cs-CPD or 5-NBene-2,2-DM resulted in deposition
of melanin as distinct ‘‘supranuclear caps’’ (Gates and Zimmermann,
1953), on the side of nuclei closest to the skin surface (Fig 9B, D),
thereby providing the greatest protection of DNA from sunlight.
Supranuclear caps can also be observed in guinea pig skin following
treatment with UVB or UVB 1 MSH (Bolognia et al, 1989). Thus,
diols appear to result in a physiologically functional melanogenic
response that parallels that likely to be caused by direct exposure to
sunlight, or indirectly as a result of sunlight stimulated MSH release.
Our observation of a diminution of melanogenic response from the
Figure 8. Guinea pigs treated with diols showing pigmentation
responses. (A) Nair (a), 10.95 M 1,2-PD (b), 4 M 3,3-DM-1,2-BD (c), and
8.7 M 1,2-cs-CPD (d) shown in the lower row of treatment spots (the upper
row is from an unrelated experiment). (B) 8.7 M 1,2-cs-CPD (a–d in upper
row) or 10.6 M 1,2-PD (a–d in lower row) in 20% ETOH, showing that
diminution of response along the anterior-posterior axis is greater for 1,2-PD
than for 1,2-cs-CPD. (C, D) 10.6 M 1,2-PD (a–d in upper row) and 1 M 5-
NBene-2,2-DM/8.5 M 1,2-PD (a–d in lower row) in 20% ETOH with 2%
2P showing diminution of response to 1,2-PD (upper row), but little diminution
of response to 5-NBene-2,2-DM/1,2-PD.
Figure 9. Biopsies from guinea pigs showing histologic features of
pigmentation responses. (A) Biopsy taken from untreated control spot located
between c and d spots of guinea pig in Fig 8C, showing dendritic melanocyte
in basal layer of epidermis (arrow); (B) biopsy taken from 8.7 M 1,2-cs-CPD
treated spot of guinea pig in Fig 8B (c in upper row), showing increased
melanin content in epidermis and formation of ‘‘supranuclear caps’’ (e.g., arrow);
(C) biopsy taken from 10.6 M 1,2-PD/2% 2P treated spot of guinea pig shown
in Fig 8C; (D) biopsy taken from 1 M 5-NBene-2,2-DM/8.5 M 1,2-PD/2%
2P treated spot of guinea pig shown in Fig 8C (c in lower row) showing
increased melanin content and supranuclear caps (arrow). Scale bars, 100 µm.
anterior to the posterior regions of guinea pigs is reminiscent of the
well known anterior-posterior diminution of response to agents that
induce allergic contact dermatitis in guinea pigs (Magnusson and
Kligman, 1970). Melanogenesis associated with contact dermatitis in
guinea pigs has been reported (Imokawa and Kawai, 1987); however,
induction of melanogenesis as a result of allergic contact dermatitis is
associated with inflammation and resultant deposition of melanin in
the dermis (Imokawa and Kawai, 1987), neither of which were
observed in our experiments. Thus, the anterior-posterior axis of
melanogenic response observed in this study is probably a reflection
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of regional differences in skin biology, perhaps a function of com-
pound transport.
Although the mechanism of action of the diols presented in this
study has not yet been established, there is evidence showing that 1,2-
PD exerts considerable biologic activity. For example, previous studies
have shown that 1,2-PD (i) enhances the effect of follicle stimulating
hormone on ovulation in sheep (Lopez-Sebastian et al, 1993), (ii)
reduces the androgenic effect of testosterone in quail (Deviche and
Balthazart, 1987), (iii) causes parthenogenetic activation of mouse and
human oocytes (Gook et al, 1995 and references therein), (iv) reduces
mouse bladder epithelial cell DNA synthesis and the number of
tetraploid and octoploid cells (Farsund, 1978), (iv) reduces mouse
lymph node proliferation in response to 2,4-dinitrochlorobenzene
(Heylings et al, 1996), and (iv) enhances rat liver microsomal enzyme
activities (Dean and Stock, 1974). These studies indicate that 1,2-PD
may either interact with steroid receptors, or act by stimulation of
steroid metabolism or deactivation. In this regard, we have found that
β-estradiol stimulates melanin production in S91 cells 3-fold over
control levels when added to the media (data not shown), and Dewhurst
et al (1996) have found that β-estradiol inhibits melanoma invasiveness.
Although there is little information regarding the biologic activity
of the other diols examined in this study, there is considerable literature
on the use of NBane derivatives in pharmaceuticals, cosmetics, and
perfumes (reviewed in Buchbauer et al, 1991a, b, 1992). NBane
derivatives are used as anti-viral, anti-cancer, and anti-convulsive drugs,
analgesics, diuretics, anti-inflammatory agents, and antibiotics, to name
a few applications (Buchbauer et al, 1991a, b; Zhang et al, 1994; Posner
et al, 1994; Jager et al, 1995). Incorporation of NBane related structures
into drugs can increase potency by providing a conformationally rigid
structure that enhances stereo-specific biologic activity, and a bulkiness
that provides protection from biodegradative processes (Iwasaki et al,
1992). Further work is needed to clarify how incorporation of
substituent groups in NBane derivatives increases their activity, particu-
larly in the case of substituent groups that are otherwise inactive.
This study demonstrates that certain diols have the potential to be
used as tanning agents. Further study is needed to evaluate their
usefulness as chemotherapeutic differentiation agents. Analysis of the
activity of additional compounds of this class and the elucidation of
the mechanism of action will be of considerable interest.
Guinea pig experiments were done at Biocon, Inc., Rockville, Maryland with assistance
from resident staff. Histology slides were prepared and stained by American HistoLabs,
Inc., Gaithersburg, Maryland. Electron microscopy was done by Tim Maugel, Director
of the Laboratory for Biological Ultrastructure, Department of Zoology, University of
Maryland, College Park, Maryland.
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